ACS sensors · 2026
Frequency-Domain Photobleaching Denoising for Sensitive Extracellular Vesicle Detection Using Fluorescence Microscopy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kang Ji Soo, Yun Hyo Geun, Shin Suyeon, Hwang So Hyun, Shin Hee Sik, Hong Jinhwa, Moon Dong Ge Ra Mi, Lim Soon Young, Roh Hyeyeon, Park Kyong Hwa, Choi Sungyoung
Аннотация
Extracellular vesicles (EVs) are promising biomarkers for non-invasive cancer diagnostics, but their nanoscale size and correspondingly weak fluorescence signals make single-particle detection challenging without specialized, high-cost instrumentation. Here, we present a fast Fourier transform (FFT)-based computational imaging approach for EV analysis, termed EV-FFT, which repurposes fluorophore photobleaching into a frequency-domain signature for robust single-nanoparticle detection. EV-FFT transforms time-resolved fluorescence trajectories into Fourier space to suppress high-frequency stochastic noise while retaining the slow photobleaching component characteristic of nanoscale emitters. We validated EV-FFT using EVs from multiple cancer cell lines across eight protein markers, with signals showing strong concordance with ELISA measurements. In a proof-of-concept breast-cancer cohort, an eight-marker EV-FFT panel distinguished patients (stage II/IV) from healthy controls, achieving 97.2% sensitivity and 99.3% specificity at the Youden-index-optimized threshold (bootstrap 95% confidence intervals: 84.1-100% and 87.5-100% for sensitivity and specificity, respectively), outperforming conventional single-frame imaging (78.9%/91.1%). By improving sensitivity through computation rather than hardware complexity, EV-FFT enables accessible, high-precision EV immunophenotyping for cancer classification.